Myeloid

245 drugs in development·93 companies·1 clinical trial

Drug Pipeline by Phase

Approved(21)

Drug	Company
company's product candidate uproleselan	CRESCENT BIOPHARMA, INC. (CBIO)
daurismo	PFIZER INC (PFE)
fulphila	Mylan II B.V. (MYL)
hydroxyurea	AVEDRO INC (AVDR)
imatinib	Amneal Pharmaceuticals, Inc. (AMRX)
imatinib	Teva Pharmaceutical Industries Limited (TEVA)
imatinib	Mylan II B.V. (MYL)
imatinib	SUNSET ISLAND GROUP (SUN)
imatinib	Aptinyx Inc. (APTX)
imatinib	DR REDDYS LABORATORIES LTD (RDY)
imkeldi	CG Oncology, Inc. (CGON)
komzifti	Kura Oncology, Inc. (KURA)
nilotinib	Mersana Therapeutics, Inc. (MRSN)
nilotinib	Aptinyx Inc. (APTX)
nilotinib	DR REDDYS LABORATORIES LTD (RDY)
nypozi	GT Biopharma, Inc. (GTBP)
Revuforj	Syndax Pharmaceuticals Inc (SNDX)
rezlidhia	RIGEL PHARMACEUTICALS INC (RIGL)
ROLVEDON	Assertio Holdings, Inc. (ASRT)
udenyca	Coherus Oncology, Inc. (CHRS)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(55)

Drug	Company
ara-c±ida	SUNSHINE BIOPHARMA INC. (SBFM)
azacitadine	GH Research PLC (GHRS)
BG-75202	BeOne Medicines Ltd. (ONC)
BGB-11417	BeOne Medicines Ltd. (ONC)
bleximenib	GH Research PLC (GHRS)
bosutinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
cellcept	ENANTA PHARMACEUTICALS INC (ENTA)
cellcept	Filana Therapeutics Inc. (FLNA)
cellcept	Structure Therapeutics Inc. (GPCR)
ceplene	IMMUNE PHARMACEUTICALS INC (IMNP)
Cladribine	Jazz Pharmaceuticals plc (JAZZ)
clifutinib	SUNSHINE BIOPHARMA INC. (SBFM)
CPX-351	Jazz Pharmaceuticals plc (JAZZ)
Cytarabine	Jazz Pharmaceuticals plc (JAZZ)
Cytarabine	Merus N.V. (MRUS)
Cytarabine + Daunorubicin + Gilteritinib	Merus N.V. (MRUS)
Cytarabine + Daunorubicin + Gilteritinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Daunorubicin	AbbVie Inc. (ABBV)
Daunorubicin	Jazz Pharmaceuticals plc (JAZZ)
Daunorubicin Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Daunorubicin Hydrochloride	Merus N.V. (MRUS)
flag-ida	SUNSHINE BIOPHARMA INC. (SBFM)
galinpepimut-s	SELLAS Life Sciences Group, Inc. (SLS)
gilteritinib	GH Research PLC (GHRS)
Gilteritinib Fumarate	Assertio Holdings, Inc. (ASRT)
gm-csf	SELLAS Life Sciences Group, Inc. (SLS)
HiDAC	Merus N.V. (MRUS)
High intensity therapies	Structure Therapeutics Inc. (GPCR)
hmpl-306 regimen	HUTCHMED (China) Ltd (HMDCF)
Idarubicin	AbbVie Inc. (ABBV)
Intensive Chemotherapy Regimen	Syndax Pharmaceuticals Inc (SNDX)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
JCAR017 + venetoclax	Merus N.V. (MRUS)
Liposome-encapsulated Daunorubicin-Cytarabine	Merus N.V. (MRUS)
Liposome-encapsulated Daunorubicin-Cytarabine	Jazz Pharmaceuticals plc (JAZZ)
lodac	SUNSHINE BIOPHARMA INC. (SBFM)
Low intensity therapies	Structure Therapeutics Inc. (GPCR)
Low intensity therapies	Crinetics Pharmaceuticals, Inc. (CRNX)
nilotinib	GH Research PLC (GHRS)
olverembatinib	CHINA PHARMA HOLDINGS, INC. (CPHI)
pevonedistat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
pevonedistat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
ponatinib 30mg od	GH Research PLC (GHRS)
ponatinib 45mg od	GH Research PLC (GHRS)
Revumenib	UNITED THERAPEUTICS Corp (UTHR)
salvage chemotherapy regimen	HUTCHMED (China) Limited (HCM)
salvage chemotherapy regimen	HUTCHMED (China) Ltd (HMDCF)
Tacrolimus	Structure Therapeutics Inc. (GPCR)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Venetoclax	ENANTA PHARMACEUTICALS INC (ENTA)
Venetoclax	UNITED THERAPEUTICS Corp (UTHR)
Venetoclax	Merus N.V. (MRUS)
Venetoclax	Crinetics Pharmaceuticals, Inc. (CRNX)
Venetoclax 400	UNITED THERAPEUTICS Corp (UTHR)
Vyxeos	Jazz Pharmaceuticals plc (JAZZ)

Phase 2(60)

Drug	Company
ABBV-787	AbbVie Inc. (ABBV)
abl001/asciminib	Novartis AG (NVS)
acr-6840	Acrivon Therapeutics, Inc. (ACRV)
ALT-803	ImmunityBio, Inc. (IBRX)
Asciminib	Novartis AG (NVS)
bcr-abl tyrosine kinase inhibitor	GH Research PLC (GHRS)
BP1001	BIO-PATH HOLDINGS, INC. (BPTH)
Busulfan	Valneva SE (VALN)
Busulfan	Merus N.V. (MRUS)
cc-486	BRISTOL MYERS SQUIBB CO (BMY)
Cytarabine	ENANTA PHARMACEUTICALS INC (ENTA)
daunorubicin	Merus N.V. (MRUS)
Daunorubicin	ENANTA PHARMACEUTICALS INC (ENTA)
daunorubicin or idarubicin	Novartis AG (NVS)
daunorubicin or idarubicin	NOVARTIS AG (NVSEF)
Daunorubicin or Idarubicin	Merus N.V. (MRUS)
dfv890	Novartis AG (NVS)
dfv890	Novartis AG (NVS)
Enasidenib	Merus N.V. (MRUS)
Filgrastim	Merus N.V. (MRUS)
Flotetuzumab	MACROGENICS INC (MGNX)
fludarabine	Novartis AG (NVS)
fludarabine	NOVARTIS AG (NVSEF)
Fludarabine	Merus N.V. (MRUS)
Fludarabine	Valneva SE (VALN)
Fludarabine Phosphate	Merus N.V. (MRUS)
G-CSF	ImmunityBio, Inc. (IBRX)
gemtuzumab ozogamicin	GH Research PLC (GHRS)
Gemtuzumab Ozogamicin	Merus N.V. (MRUS)
Gemtuzumab Ozogamicin	ENANTA PHARMACEUTICALS INC (ENTA)
Gilteritinib	Merus N.V. (MRUS)
imatinib	Novartis AG (NVS)
Inotuzumab ozogamicin	Merus N.V. (MRUS)
Luveltamab tazevibulin	SUTRO BIOPHARMA, INC. (STRO)
Melphalan	Valneva SE (VALN)
Melphalan	Merus N.V. (MRUS)
MHA	Jazz Pharmaceuticals plc (JAZZ)
mitoxantrone	Novartis AG (NVS)
mitoxantrone	GH Research PLC (GHRS)
mitoxantrone	NOVARTIS AG (NVSEF)
Mitoxantrone	Jazz Pharmaceuticals plc (JAZZ)
mt-401	Marker Therapeutics, Inc. (MRKR)
mt-401-ots	Marker Therapeutics, Inc. (MRKR)
Mycophenolate mofetil	ImmunityBio, Inc. (IBRX)
nexi-001	NexImmune, Inc. (NEXI)
Olutasidenib	Merus N.V. (MRUS)
oxi4503	Oncotelic Therapeutics, Inc. (OTLC)
Pegfilgrastim	Merus N.V. (MRUS)
pivekimab sunirine	ImmunoGen, Inc. (IMGN)
Recombinant Granulocyte Colony-Stimulating Factor	Jazz Pharmaceuticals plc (JAZZ)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
Tacrolimus	ImmunityBio, Inc. (IBRX)
tagraxofusp	STEMLINE THERAPEUTICS INC (STML)
tamibarotene	Syros Pharmaceuticals, Inc. (SYRS)
tcb008	TC BioPharm (Holdings) plc (TCBWF)
tern-501	Terns Pharmaceuticals, Inc. (TERN)
tern-701	Terns Pharmaceuticals, Inc. (TERN)
tern-801	Terns Pharmaceuticals, Inc. (TERN)
Venetoclax	Valneva SE (VALN)
Vincristine Sulfate Liposome	Merus N.V. (MRUS)

Phase 1(66)

Drug	Company
ACLX-002	Arcellx, Inc. (ACLX)
ADCLEC.syn1 CAR T cells	Merus N.V. (MRUS)
ADCLEC.syn1 CAR T cells	Filana Therapeutics Inc. (FLNA)
Alvocidib	AbbVie Inc. (ABBV)
AMG 176	AbbVie Inc. (ABBV)
ascentage pharma hqp1351 bioavailable inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
astx727	CG Oncology, Inc. (CGON)
ASTX727	Syndax Pharmaceuticals Inc (SNDX)
bg-75202	BeOne Medicines Ltd. (ONC)
Bleximenib	Merus N.V. (MRUS)
blinatumomab	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
BMF-500	Biomea Fusion, Inc. (BMEA)
CB-012	Caribou Biosciences, Inc. (CRBU)
cb-5339	CASI Pharmaceuticals, Inc (DE) (CASI)
CD371-specific/YSNVz/I-18 CAR T cells	Merus N.V. (MRUS)
Chemotherapy Regimen	Syndax Pharmaceuticals Inc (SNDX)
Conditioning chemotherapy	Filana Therapeutics Inc. (FLNA)
Cytarabine	Structure Therapeutics Inc. (GPCR)
Cytarabine	Accustem Sciences Inc. (ACUT)
Cytarabine	Syndax Pharmaceuticals Inc (SNDX)
elvn-001	Enliven Therapeutics, Inc. (ELVN)
Etoposide Phosphate	Accustem Sciences Inc. (ACUT)
fludarabine	Sanofi (SNYNF)
fludarabine	Sanofi (SNY)
Fludarabine	AbbVie Inc. (ABBV)
Gemtuzumab Ozogamicin	Jazz Pharmaceuticals plc (JAZZ)
Gilteritinib	Jazz Pharmaceuticals plc (JAZZ)
Gilteritinib	AbbVie Inc. (ABBV)
Granulocyte Colony-Stimulating Factor	AbbVie Inc. (ABBV)
HiDAC	Syndax Pharmaceuticals Inc (SNDX)
hypomethylation agent	BeOne Medicines Ltd. (BEIGF)
hypomethylation agent	BeOne Medicines Ltd. (ONC)
Iadademstat	Merus N.V. (MRUS)
Idarubicin	Structure Therapeutics Inc. (GPCR)
Imetelstat	Assertio Holdings, Inc. (ASRT)
jnj-90189892	GH Research PLC (GHRS)
KT-253	Kymera Therapeutics, Inc. (KYMR)
lisaftoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
MGD024	MACROGENICS INC (MGNX)
Mitoxantrone Hydrochloride	Accustem Sciences Inc. (ACUT)
Navtemadlin	Merus N.V. (MRUS)
nc525	NextCure, Inc. (NXTC)
olverembatinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Pitavastatin	UNITED THERAPEUTICS Corp (UTHR)
Pivekimab Sunirine	AbbVie Inc. (ABBV)
Pivekimab Sunirine	Structure Therapeutics Inc. (GPCR)
quizartinib	Kura Oncology, Inc. (KURA)
Revumenib	AbbVie Inc. (ABBV)
Revumenib	Syndax Pharmaceuticals Inc (SNDX)
Revumenib	Merus N.V. (MRUS)
sar445419	Sanofi (SNYNF)
sar445419	Sanofi (SNY)
sgr-2921	Schrodinger, Inc. (SDGR)
siremadlin	Novartis AG (NVS)
sl-172154	Shattuck Labs, Inc. (STTK)
SNDX-5613	Syndax Pharmaceuticals Inc (SNDX)
SNDX-5613	Merus N.V. (MRUS)
Tazemetostat	Merus N.V. (MRUS)
Venetoclax	Syndax Pharmaceuticals Inc (SNDX)
Venetoclax	Actinium Pharmaceuticals, Inc. (ATNM)
voruciclib	Lite Strategy, Inc. (LITS)
vyxeos	GH Research PLC (GHRS)
Vyxeos liposomal	Jazz Pharmaceuticals plc (JAZZ)
ze 50-0134	Rani Therapeutics Holdings, Inc. (RANI)
ze50-0134	Rani Therapeutics Holdings, Inc. (RANI)
ZN-d5	Zentalis Pharmaceuticals, Inc. (ZNTL)

Preclinical(14)

Drug	Company
ACLX-004	Arcellx, Inc. (ACLX)
ALTA-002	ALX ONCOLOGY HOLDINGS INC (ALXO)
BCR-ABL TKI	Theseus Pharmaceuticals, Inc. (THRX)
cd38-gear-nk	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-GEAR-NK	Coeptis Therapeutics Holdings Inc. (COEP)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
gb3226	Damora Therapeutics, Inc. (DMRA)
oncotox-aml	OMEROS CORP (OMER)
prime edited scip	Prime Medicine, Inc. (PRME)
rasp-101	ACTAVIA LIFE SCIENCES, INC. (RASP)
rasp-201	ACTAVIA LIFE SCIENCES, INC. (RASP)
rasp-301	ACTAVIA LIFE SCIENCES, INC. (RASP)
tp-2846	TETRAPHASE PHARMACEUTICALS INC (TTPH)
tp-2846	LA JOLLA PHARMACEUTICAL CO (LJPC)

Unknown(1)

Drug	Company
BST-236	Ayala Pharmaceuticals, Inc. (ADXS)

Clinical(1)

Drug	Company
ast-vac1	ASTERIAS BIOTHERAPEUTICS, INC. (AST)

Phase 1/Phase 2(15)

Drug	Company
asciminib adult formulation group	Novartis AG (NVS)
asciminib pediatric formulation group	Novartis AG (NVS)
CLN-049	Cullinan Therapeutics, Inc. (CGEM)
cobicistat	Syndax Pharmaceuticals Inc (SNDX)
debio 1562m	HWH International Inc. (HWH)
ft-2102	Forma Therapeutics Holdings, Inc. (FMTX)
mb-dnpm1-tcr.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
nkx101	Nkarta, Inc. (NKTX)
ponatinib	Incyte Corp. (INCY)
ponatinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Posaconazole	BeOne Medicines Ltd. (ONC)
reduced-dose hht	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
sar443579	Sanofi (SNY)
standard-dose hht	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
UCART123v1.2	Cellectis S.A. (CLLS)

Phase 2/Phase 3(4)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
annamycin	Moleculin Biotech, Inc. (MBRX)
liposomal annamycin	Moleculin Biotech, Inc. (MBRX)
liposomal annamycin injection in combination with cytarabine	Moleculin Biotech, Inc. (MBRX)

Phase 4(8)

Drug	Company
asciminib	Novartis AG (NVS)
bms-986497	BRISTOL MYERS SQUIBB CO (BMY)
bosutinib	Novartis AG (NVS)
cyp1a2	RIGEL PHARMACEUTICALS INC (RIGL)
nilotinib	Novartis AG (NVS)
nilotinib	Novartis AG (NVS)
ponatinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Venetoclax	AbbVie Inc. (ABBV)

Compare drugs

company's product candidate uproleselan vs daurismo company's product candidate uproleselan vs fulphila company's product candidate uproleselan vs hydroxyurea

Frequently asked questions

How many drugs are in development for Myeloid?

BioSniper tracks 245 drugs in development for Myeloid across 93 companies.

How many clinical trials target Myeloid?

There are 1 clinical trial targeting Myeloid tracked by BioSniper.

Deep-dive into Myeloid

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis